Compare J Resources Asia Pasifik Tbk. (PSAB) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J Resources Asia Pasifik Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? J Resources Asia Pasifik Tbk. trades at Rp580 (market cap 15.48T, 68.06M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: J Resources Asia Pasifik Tbk. is far larger — about 148.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PSAB | SCPI | |
|---|---|---|
Market Cap | 15.48T | 104.4B |
Volume | 68.06M | — |
Lot | 680.58K | — |
Turnover | 39.21B | — |
Average Price | 576.11 | — |
Value | 39.21B | — |
Indicative Equilibrium Price | 580 | — |
Indicative Equilibrium Volume | 21.68K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J Resources Asia Pasifik Tbk.
PT J Resources Asia Pasifik Tbk (the Company) was established under the name of PT Pelita Sejahtera Abadi Tbk on January 14, 2002. PT Pelita Sejahtera Abadi Tbk is an Indonesia-based service company. The Company operates food courts and provides catering services. In addition, it is engaged in the transportation, telecommunication and real estate sectors. The Company is headquartered in Semarang, Indonesia.
Read more on PSAB →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
